PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

PHASE4CompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Cancer-related Fatigue
Interventions
DRUG

Astragalus Polysaccharides 500 mg

PG2 (500 mg in 500 ml saline), t.i.w. via i.v. infusion for 2.5-3.5 hours over 2 treatment cycles (8 weeks)

DRUG

Astragalus Polysaccharides 250 mg

PG2 (500 mg in 500 ml saline), t.i.w. via i.v. infusion for 2.5-3.5 hours over 2 treatment cycles (8 weeks)

Trial Locations (9)

104

Mackay Memorial Hospital, Taipei

114

Tri-Service General Hospital, Taipei

204

Chang Gung Memorial Hospital, Lovers Lake Branch, Keelung

235

Taipei Medical University -Shung Ho Hospital, Taipei

333

Chang Gung Memorial Hospital, Linkou, Taoyuan District

404

China Medical University Hospital, Taichung

500

Changhua Christian Hospital, Changhua

736

Chi Mei Hospital, Loiuying Campus, Tainan City

833

Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung City

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY